Lean body mass gain in patients with head and neck squamous cell cancer treated perioperatively with a protein- and energy-dense nutritional supplement containing eicosapentaenoic acid

Head and Neck

Volumn 33, Issue 7, 2011, Pages 1027-1033

  Weed, Harrison G ^a   Ferguson, Maree L ^b   Gaff, Robin L ^c   Hustead, Deborah S ^d   Nelson, Jeffrey L ^d   Voss, Anne C ^d  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c Clinical Nutrition   (United States)

^d ABBOTT LABORATORIES   (United States)

Author keywords

cachexia; eicosanoids; fish oils; head and neck neoplasms; squamous cell cancer

Indexed keywords

FISH OIL; ICOSAPENTAENOIC ACID;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; BODY WEIGHT DISORDER; CANCER RELATED WEIGHT LOSS; CANCER SURGERY; DIET SUPPLEMENTATION; FEMALE; HEAD AND NECK CANCER; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INFLAMMATION; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; WEIGHT REDUCTION;

ADULT; AGED; BODY COMPOSITION; CACHEXIA; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DIETARY PROTEINS; DIETARY SUPPLEMENTS; EICOSAPENTAENOIC ACID; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 79959219159     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21580     Document Type: Article

References (54)

1. American Academy of Otolaryngology-Head and Neck Surgery. Head and Neck Cancer. Available at. Accessed July 18, 2007.
2. Berrino F, Gatta G, Eurocare Working Group. Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumors. Eur J Cancer 1998; 34: 2154-2161. (Pubitemid 29036880)
3. Rodriguez-Monge EJ, Shin DM, Lippman SM,. Head and neck cancer. Accessed July 18, 2007.
4. Couch M, Lai V, Cannon T, et al. Cancer cachexia syndrome in head and neck cancer patients: Part I. Diagnosis, impact on quality of life and survival, and treatment. Head Neck 2007; 29: 401-411. (Pubitemid 46623505)
5. Isenring EA, Capra S, Bauer JD,. Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area. Br J Cancer 2004; 91: 447-452. (Pubitemid 39093562)
6. van Bokhorst-De Van Der Schueren MA, van Leeuwen PA, Sauerwein HP, Kuik DJ, Snow GB, Quak JJ,. Assessment of malnutrition parameters in head and neck cancer and their relation to postoperative complications. Head Neck 1997; 19: 419-425. (Pubitemid 27293225)
7. Bellantone R, Doglietto GB, Bossola M, et al. Preoperative parenteral nutrition in the high risk surgical patient. J Parenter Enteral Nutr 1988; 12: 195-197. (Pubitemid 18087296)
8. Aouon JP, Baroudi J, Geahchan N,. Prevalence of malnutrition in general surgical patients. J Med Liban 1993; 41: 57-61.
9. Dempsey DT, Mullen JL, Buzby GP,. The link between nutritional status and clinical outcome: can nutritional intervention modify it? Am J Clin Nutr 1988; 47: 352-356. (Pubitemid 18061707)
10. van Bokhorst-De Van Der Schueren MA, Quak JJ, von Blomberg-van der Flier BM, et al. Effect of perioperative nutrition, with and without arginine supplementation, on nutritional status, immune function, postoperative morbidity, and survival in severely malnourished head and neck cancer patients. Am J Clin Nutr 2001; 73: 323-332. (Pubitemid 32109863)
11. van Bokhorst-De Van Der Schueren MA, van Leeuwen PA, Kuik DJ, et al. The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer 1999; 86: 519-527. (Pubitemid 29347416)
12. DeWys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980; 69: 491-497. (Pubitemid 10018703)
13. Andreyev HJ, Norman AR, Oates J, Cunningham D,. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 1998; 34: 503-509. (Pubitemid 28179346)
14. Nozoe T, Kimura Y, Ishida M, Saeki H, Korenaga D, Sugimachi K,. Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma. Eur J Surg Oncol 2002; 28: 396-400.
15. Fearon KC, Carter DC,. Cancer cachexia. Ann Surg 1988; 208: 1-5.
16. Tisdale MJ,. Biology of cachexia. J Natl Cancer Inst 1997; 89: 1763-1773. (Pubitemid 27516230)
17. Oliff A, Defeo-Jones D, Boyer M, et al. Tumors secreting human TNF/cachectin induce cachexia in mice. Cell 1987; 50: 555-563.
18. Tracey KJ, Wei H, Manogue KR, et al. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 1988; 167: 1211-1227.
19. McNamara MJ, Alexander HR, Norton JA,. Cytokines and their role in the pathophysiology of cancer cachexia. J Parenter Enteral Nutr 1992; 16: 50S-55S.
20. Chen Z, Malhotra PS, Thomas GR, et al. Expression of proinflammatory and proangiogenic cytokines in patients withy head and neck cancer. Clin Cancer Res 1999; 5: 1369-1379. (Pubitemid 29282941)
21. Druzgal CH, Chen Z, Yeh NT, et al. A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma. Head Neck 2005; 27: 771-784. (Pubitemid 41266181)
22. Riedel F, Zaiss I, Herzog D, Gotte K, Naim R, Hormann K,. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma. Anti-cancer Res 2005; 25: 2761-2765.
23. Todorov P, Cariuk P, McDevitt T, Coles B, Fearon K, Tisdale M,. Characterization of a cancer cachectic factor. Nature 1996; 379: 739-742. (Pubitemid 26061738)
24. Visser M, Pahor M, Taaffe DR, et al. Relationship of interleukin-6 and tumor necrosis factor-α with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 2002; 57: M326-M332. (Pubitemid 34464974)
25. Ovesen L, Allingstrup L, Hannibal J, Mortensen EL, Hansen OP,. Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. J Clin Oncol 1993; 11: 2043-2049. (Pubitemid 23304632)
26. Evans WK, Nixon DW, Daly JM, et al. A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer. J Clin Oncol 1987; 5: 113-124. (Pubitemid 17007865)
27. Endres S, Ghorbani R, Kelly VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320: 265-271. (Pubitemid 19045549)
28. Tisdale MJ, Beck SA,. Inhibition of tumour-induced lipolysis in vitro and cachexia and tumour growth in vivo by eicosapentaenoic acid. Biochem Pharmacol 1991; 41: 103-107.
29. Wigmore SJ, Ross JA, Falconer JS, et al. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 1996; 12: S27-S30.
30. Wigmore SJ, Fearon KC, Maingay JP, Ross JA,. Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin Sci (Lond) 1997; 92: 215-221. (Pubitemid 27075725)
31. Todorov P, Cariuk P, McDevitt T, et al. Characterization of a cancer cachectic factor. Nature 1996; 379: 739-742. (Pubitemid 26061738)
32. Tisdale MJ,. Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia. Nutrition 1996; 12: S31-S33.
33. Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KCH,. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 1999; 81: 80-86. (Pubitemid 29415495)
34. Barber MD, Fearon KCH, Tisdale MJ, McMillian DC, Ross JA,. Effect of fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutr Cancer 2001; 40: 118-124. (Pubitemid 34274917)
35. Fearon KCH, von Meyenfeldt MF, Moses AGW, et al. Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomized double blind trial. Gut 2003; 52: 1479-1486. (Pubitemid 37176729)
36. Moses AW, Slater C, Preston T, Barber MD, Fearon KCH,. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 2004; 90: 996-1002. (Pubitemid 38495818)
37. Guarcello M, Riso S, Andrea FD,. EPA-enriched oral nutritional support in patients with lung cancer: effects on nutritional status and quality of life. Nutr Therapy Metab 2006; 24: 168-175.
38. Read JA, Beale PJ, Volker DH, Smith N, Childs A, Clarke SJ,. Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial. Support Care Cancer 2007; 15: 301-307. (Pubitemid 46295216)
39. Ryan A, Reynolds JV, Healy L, et al. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg 2008; 249: 355-363.
40. Bayram I, Erbey F, Celik N, Nelson JL, Tanyeli A,. The use of a protein and energy dense eicosapentaenoic acid containing supplement for malignancy-related weight loss in children. Pediatr Blood Cancer 2009; 52: 571-574.
41. Maciejewski B, Sklandowski K, Pilecki B, et al. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity. Radiother Oncol 1996; 40: 137-145. (Pubitemid 26276678)
42. Trotti A, Bellm LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003; 66: 253-262. (Pubitemid 36556043)
43. Adelstein DJ, Saxton JP, Lavertu P, et al. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results. Head Neck 1997; 19: 567-575. (Pubitemid 27407310)
44. de Luis DA, Izaola O, Aller R, et al. A randomized clinical trial with oral immunonutrition (n-3-enhanced formula vs. arginine-enhanced formula) in ambulatory head and neck cancer patients. Ann Nutr Metab 2005; 49: 95-99. (Pubitemid 40827630)
45. de Luis DA, Izaola O, Aller R, et al. A randomized clinical trial with two omega 3 fatty acid enhanced oral supplements in head and neck cancer ambulatory patients. Eur Rev Med Pharmacol Sci 2008; 12: 177-181.
46. Hannan WJ, Cowen SJ, Plester CE, Fearon KC, deBeau A,. Comparison of bio-impedance spectroscopy and multi-frequency bio-impedance analysis for the assessment of extracellular and total body water in surgical patients. Clin Sci (Lond) 1995; 89: 651-658.
47. Bauer JD, Capra S,. Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy-a pilot study. Support Care Cancer 2005; 13: 270-274. (Pubitemid 40576515)
48. Gritz ER, Carmack CL, deMoor C, et al. First year after head and neck cancer: quality of life. J Clin Oncol 1999; 17: 352-360. (Pubitemid 29022414)
49. Petruson KM, Silander EM, Hammerlid EB,. Quality of life as predictor or weight loss in patients with head and neck cancer. Head Neck 2005; 27: 302-310. (Pubitemid 40418602)
50. Haque R, Contreras R, McNicoll MP, Eckberg EC, Petitti DB,. Surgical margins and survival after head and neck cancer surgery. BMC Ear Nose Throat Disord 2006; 6: 1-6.
51. Medow MA, Weed HG, Schuller DE,. Simple predictors of survival in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2002; 128: 1282-1286. (Pubitemid 35403307)
52. Terrell JE, Ronis DL, Fowler KE, et al. Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2004; 130: 401-408. (Pubitemid 38456313)
53. Eritsland J, Arnesen H, Seljeflot I, Kierulf P,. Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease. Blood Coagul Fibrinolysis 1995; 6: 17-22.
54. Watson PD, Joy PS, Nkonde C, Hessen SE, Karalis DG,. Comparison of bleeding complications with omega-3 fatty acids + aspirin + clopidogrel - versus - aspirin + clopidogrel in patients with cardiovascular disease. Am J Cardiol 2009; 104: 1052-1054. Epub 2009 Aug 25.